Epidemiology and Disease Control Unit, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Trop Med Int Health. 2010 Jul;15 Suppl 2(Suppl 2):55-62. doi: 10.1111/j.1365-3156.2010.02562.x.
In 2005 a visceral leishmaniasis (VL) elimination initiative was launched on the Indian subcontinent, with early diagnosis based on a rapid diagnostic test and treatment with the oral drug miltefosine as its main strategy. Several recent studies have signaled underreporting of VL cases in the region. Information on treatment outcomes is scanty. Our aim was to document VL case management by the primary health care services in India.
We took a random sample of all VL patients registered in rural primary health care (PHC) facilities of Muzaffarpur district, Bihar, India during 2008. Patients were traced at home for an interview and their records were reviewed. We recorded patient and doctor delay, treatment regimens, treatment outcomes and costs incurred by patients.
We could review records of all 150 patients sampled and interview 139 patients or their guardian. Most patients (81%) had first presented to unqualified practitioners; median delay before reaching the appropriate primary healthcare facility was 40 days (IQR 31-59 days). Existing networks of village health workers were under-used. 48% of VL patients were treated with antimonials; 40% of those needed a second treatment course. Median direct expenditure by patients was 4000 rupees per episode (IQR 2695-5563 rupees), equivalent to almost 2 months of household income.
In 2008 still critical flaws remained in VL case management in the primary health care services in Bihar: obsolete use of antimonials with high failure rates and long patient delay. To meet the target of the VL elimination, more active case detection strategies are needed, and village health worker networks could be more involved. Costs to patients remain an obstacle to early case finding.
2005 年,在印度次大陆启动了内脏利什曼病(VL)消除计划,早期诊断基于快速诊断测试,以口服药物米替福新为主要策略。最近的几项研究表明,该地区 VL 病例报告不足。有关治疗结果的信息很少。我们的目的是记录印度初级卫生保健服务中 VL 病例的管理情况。
我们从印度比哈尔邦穆扎法尔布尔区农村初级卫生保健(PHC)设施中随机抽取了所有 2008 年登记的 VL 患者作为样本。我们在家中追踪患者进行访谈,并审查其记录。我们记录了患者和医生的延迟、治疗方案、治疗结果以及患者的费用。
我们可以查阅抽样的 150 名患者的记录并采访了 139 名患者或其监护人。大多数患者(81%)首次就诊于无资质的医生;到达适当的初级卫生保健机构的中位延迟为 40 天(IQR 31-59 天)。现有的村庄卫生工作者网络使用不足。48%的 VL 患者接受了锑剂治疗;其中 40%需要进行第二次疗程。每位患者的直接支出中位数为 4000 卢比(IQR 2695-5563 卢比),相当于几乎 2 个月的家庭收入。
2008 年,在比哈尔邦的初级卫生保健服务中,VL 病例管理仍存在严重缺陷:陈旧的锑剂使用,失败率高,患者延迟时间长。为了实现 VL 消除目标,需要更积极的病例发现策略,并且可以更多地利用村庄卫生工作者网络。患者的费用仍然是早期发现病例的障碍。